Skip to main content

Table 3 Percentage of cells expressing surface ligands of NK activating receptors (DNAM-1 and NKG2D), and the ligands of NK cell inhibiting receptor (HLA-E) in different pMSCs

From: Preconditioning human natural killer cells with chorionic villous mesenchymal stem cells stimulates their expression of inflammatory and anti-tumor molecules

Receptors/molecule

Ligand names

Results (%)

DNAM-1

PVR (CD155)

12.17% ± 1.92%

Nectin-2 (CD112)

1.73% ± 0.63%

NKG2D

ULBP-1

7.66% ± 3.28%

ULBP-2

37.33% ± 10.27%

ULBP-3

9.00% ± .5.56%

MICA

6.33% ± 2.33%

MICB

3.330% ± 1.45%

CD94/NKG2

HLA-E

27.33% ± 9.26%

HLA-ABC

 

95.00% ± 4.40%